Study to Assess the Safety, Tolerability, and Pharmacodynamic (PD) Effects of FRM-0334 in Subjects With Prodromal to Moderate Frontotemporal Dementia With Granulin Mutation

UCSF Memory and Aging Center, San Francisco

Compass Research, LLC, Orlando

Massachusetts General Hospital, Boston

Mayo Clinic, Rochester

Perelman School of Medicine, University of Pennsylvania, Philadelphia

University Hospitals Leuven, Leuven

CHU Bordeaux Hospital Pellegrin, Bordeaux

CHU Rouen, Charles Nicolle Hospital, Rouen

IRCCS - Centro S. Giovanni di Dio FateBeneFratelli, Brescia

Neurological Clinic, University of Brescia, AO Civil Hospital of Brescia, Brescia

Fondazione Universita Gabriele D'Annunzio di Chieti, Chieti Scalo

Erasmus Medical Center, Rotterdam

The National Hospital for Neurology and Neuroscience, London